Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Ingle

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Group Practice|February 11, 1979
A group practice cancer treatment network is bornD Anderson, J N Ingle, C G Moertel
Cancer Investigation|June 17, 1998
Thrombosis of the internal jugular vein: a rare manifestation of the hypercoagulability of malignancyD Rayson, J N Ingle, R K Pruthi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Postchemotherapy rheumatismC L Loprinzi, J Duffy, J N Ingle
Cancer|February 1, 1978
The bone marrow examination in breast cancer: diagnostic considerations and clinical usefulnessJ N Ingle, D C Tormey, H K Tan
Cancer|January 1, 1995
Estrogen replacement therapy withdrawal and regression of metastatic breast cancerM V Dhodapkar, J N Ingle, D L Ahmann
Cancer Chemotherapy and Pharmacology|January 1, 1987
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patientsG Powis, P Reece, D L Ahmann, et al.
British Journal of Cancer|June 10, 2004
Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literatureC Adem, C Reynolds, J N Ingle, et al.
American Journal of Epidemiology|July 20, 2000
External radiation exposure and mortality in a cohort of uranium processing workersE Dupree-Ellis, J Watkins, J N Ingle, et al.
Endocrine-Related Cancer|March 24, 2000
Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancerJ N Ingle, V J Suman, V C Jordan, et al.
Controlled Clinical Trials|June 1, 1988
A design for phase II testing of anticancer agents within a phase III clinical trialD J Schaid, J N Ingle, S Wieand, et al.
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Group Practice|February 11, 1979
A group practice cancer treatment network is bornD Anderson, J N Ingle, C G Moertel
Cancer Investigation|June 17, 1998
Thrombosis of the internal jugular vein: a rare manifestation of the hypercoagulability of malignancyD Rayson, J N Ingle, R K Pruthi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Postchemotherapy rheumatismC L Loprinzi, J Duffy, J N Ingle
Cancer|February 1, 1978
The bone marrow examination in breast cancer: diagnostic considerations and clinical usefulnessJ N Ingle, D C Tormey, H K Tan
Cancer|January 1, 1995
Estrogen replacement therapy withdrawal and regression of metastatic breast cancerM V Dhodapkar, J N Ingle, D L Ahmann
Cancer Chemotherapy and Pharmacology|January 1, 1987
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patientsG Powis, P Reece, D L Ahmann, et al.
British Journal of Cancer|June 10, 2004
Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literatureC Adem, C Reynolds, J N Ingle, et al.
American Journal of Epidemiology|July 20, 2000
External radiation exposure and mortality in a cohort of uranium processing workersE Dupree-Ellis, J Watkins, J N Ingle, et al.
Endocrine-Related Cancer|March 24, 2000
Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancerJ N Ingle, V J Suman, V C Jordan, et al.
Controlled Clinical Trials|June 1, 1988
A design for phase II testing of anticancer agents within a phase III clinical trialD J Schaid, J N Ingle, S Wieand, et al.
Pageof 17